ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Bergenbio Asa

Bergenbio Asa (0RU5)

4,600.00
0.00
(0.00%)
Cerrado 02 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
4,600.00
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
431
0.00 Rango del Día 0.00
4,600.00 Rango de 52 semanas 4,600.00
Capitalización de Mercado [m]
Precio Anterior
4,600.00
Precio de Apertura
-
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
1,126
Acciones en circulación
2,688,689,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-64,971.75
Beneficio por acción (BPA)
-0.07
turnover
354k
Beneficio neto
-190.4M

Acerca de Bergenbio Asa

Sector
Meas & Controlling Dev, Nec
Industria
Meas & Controlling Dev, Nec
Sitio web
Sede
Bergen, Nor
Fundado
-
Bergenbio Asa is listed in the Meas & Controlling Dev sector of the London Stock Exchange with ticker 0RU5. The last closing price for Bergenbio Asa was kr4,600. Over the last year, Bergenbio Asa shares have traded in a share price range of kr 4,600.00 to kr 4,600.00.

Bergenbio Asa currently has 2,688,689,000 shares in issue. The market capitalisation of Bergenbio Asa is kr12.37 trillion. Bergenbio Asa has a price to earnings ratio (PE ratio) of -64971.75.

0RU5 Últimas noticias

BerGenBio Appoints Olav Hellebø as CEO

BerGenBio Appoints Olav Hellebø as CEO PR Newswire BERGEN, Norway, Nov. 20, 2024 BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical...

BerGenBio Appoints Olav Hellebø as CEO

BerGenBio Appoints Olav Hellebø as CEO PR Newswire BERGEN, Norway, Nov. 20, 2024 BERGEN, Norway, Nov. 20, 2024 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical...

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer

BerGenBio announces clinical data presentations highlighting the activity of its selective AXL inhibitor bemcentinib in Non-Small Cell Lung Cancer PR Newswire BERGEN, Norway, Aug. 22, 2023...

BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue

BerGenBio ASA: Approval and publication of prospectus for the preferential Rights Issue PR Newswire BERGEN, Norway, May 26, 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR...

BerGenBio ASA: Proposed partially underwritten rights issue

BerGenBio ASA: Proposed partially underwritten rights issue PR Newswire BERGEN, Norway, April 25, 2023 NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR PR Newswire BERGEN, Norway, April 18, 2023 In addition to STK11 mutations, KEAP1m identified as being associated with...

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR

BerGenBio Presents Data on STK11 Loss of Function and AXL Activation at AACR PR Newswire BERGEN, Norway, April 18, 2023 In addition to STK11 mutations, KEAP1m identified as being associated with...

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations PR Newswire BERGEN, Norway, March 9, 2023 - Global...

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations

BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations PR Newswire BERGEN, Norway, March 9, 2023 - Global...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1004600460046005014600DE
4004600460046003204600DE
120046004600460011264600DE
26004600460046008574600DE
5200460046004600330304600DE
15600460046004600762324600DE
26000460046004600476044600DE

0RU5 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bergenbio Asa?
El precio actual de las acciones de Bergenbio Asa es kr 4,600.00
¿Cuántas acciones de Bergenbio Asa están en circulación?
Bergenbio Asa tiene 2,688,689,000 acciones en circulación
¿Cuál es la capitalización de mercado de Bergenbio Asa?
La capitalización de mercado de Bergenbio Asa es NOK 12.37T
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bergenbio Asa?
Bergenbio Asa ha negociado en un rango de kr 4,600.00 a kr 4,600.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Bergenbio Asa?
El ratio precio/beneficio de Bergenbio Asa es -64.97k
¿Cuál es el ratio de efectivo a ventas de Bergenbio Asa?
El ratio de efectivo a ventas de Bergenbio Asa es 46M
¿Cuál es la moneda de reporte de Bergenbio Asa?
Bergenbio Asa presenta sus resultados financieros en NOK
¿Cuál es el último ingresos anual de Bergenbio Asa?
El último ingresos anual de Bergenbio Asa es NOK 354k
¿Cuál es el último beneficio anual de Bergenbio Asa?
El último beneficio anual de Bergenbio Asa es NOK -190.4M
¿Cuál es la dirección registrada de Bergenbio Asa?
La dirección registrada de Bergenbio Asa es M��LLENDALSBAKKEN 9, BERGEN, 5009
¿Cuál es la dirección del sitio web de Bergenbio Asa?
La dirección del sitio web de Bergenbio Asa es www.bergenbio.com
¿En qué sector industrial opera Bergenbio Asa?
Bergenbio Asa opera en el sector MEAS & CONTROLLING DEV, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TBLSTinybuild Inc.
6.50p
(44.44%)
20k
WEBWebis Holdings Plc
0.075p
(36.36%)
173.73k
REVBRevolution Beauty Group Plc
18.10p
(29.29%)
2.81M
AMGAtlas Metals Group Plc
12.25p
(28.95%)
456.51k
SYMESupply@me Capital Plc
0.0043p
(22.86%)
261.33M
POLBPoolbeg Pharma Plc
4.15p
(-41.96%)
28.51M
MILAMila Resources Plc
0.275p
(-21.43%)
1.92M
S247Smarttech247 Group Plc
8.50p
(-20.56%)
338.15k
THRUThruvision Group Plc
6.50p
(-18.75%)
175.99k
QUIZQuiz Plc
0.62p
(-16.78%)
147.62k
DGIDg Innovate Plc
0.025p
(11.11%)
861.93M
TRPTower Resources Plc
0.0375p
(4.17%)
425.3M
CPXCap-xx Limited
0.18p
(16.13%)
317.62M
NTVONativo Resources Plc
0.0019p
(0.00%)
292.58M
SYMESupply@me Capital Plc
0.0043p
(22.86%)
261.33M
campe campe 4 minutos hace
Are the defense attorneys the only ones who the Lamb's pay?  (since documentation and lawsuits say they dont pay their suppliers, contractors, or landscape guys).


UBQU
CherryTree1 CherryTree1 4 minutos hace
I see you are relatively new with your alias first created in March of 2024.
Let me say welcome.
You obviously have no clue about the potential of DCVAX.
and by the way Linda Powers is not going to sell to any Big Pharma company for 1000X less than DCVAX is worth.
There i
NWBO
CherryTree1 CherryTree1 4 minutos hace
I see you are relatively new with your alias first created in March of 2024.
Let me say welcome.
You obviously have no clue about the potential of DCVAX.
and by the way Linda Powers is not going to sell to any Big Pharma company for 1000X less than DCVAX is worth.
There i
NWBO
Alley-oop Alley-oop 4 minutos hace
Item 3.02 Unregistered Sales of Equity Securities

On December 30, 2024, Two Hands Corporation (the “Company”) issued a total of 3,000,000,000 shares of its common stock to Emil Assentato in connection with the conversion of $300,000 in outstanding notes. The shares of common stock we
TWOH
al44 al44 5 minutos hace
To ridicule their injuries while they’re just doing a hard day’s work is typical of the left, who have become the most vile people on earth.

Worth repeating endlessly

.....................al
navycmdr navycmdr 5 minutos hace
$MAGA $Boooom $BAZINGA!

https://investorshub.advfn.com/uimage/uploads/2025/1/2/dceecScreenshot_20250102_154331_X.jpg
BAZINGA BOOOOM MAGA
moondogaz moondogaz 5 minutos hace
I think it's Nostradamus, 2025 predictions. Lol.
HMBL
tabbycat tabbycat 5 minutos hace


TWOH
KILLAZILLA KILLAZILLA 6 minutos hace
NOBODY'S BUYING ANY GRIFTERS LIES....

ONLY ABLE TO DILUTE 100K TODAY...

SOOOO SADDDDD!!!

AND SOOOOO PATHETIC!!!!!
XERI
Maximilliano Maximilliano 6 minutos hace
It's known as the January Effect. Although with FCEL I'm not so sure you can bet on it.

What you can bet on today is more shares doled out to the no-news bungling inept leadership.
FCEL
Buckey Buckey 6 minutos hace
FUNNY TGL UP 70% ah
TGL
StockInfo11 StockInfo11 7 minutos hace
American Pacific Mining (USGD.c USGDF) reported 2024 field results from its Madison Project in Montana, including assays up to 80.6 g/t gold, 5.2% copper, and 136 g/t silver. Five new drill targets were identified, with a fully funded 3,000m Phase II drill program set to start this quarter. More⬇️
USGDF
SSKILLZ1 SSKILLZ1 7 minutos hace
SSKMP Managed Index (As Of 1/2/25)

Daily Performance
-0.05%

YTD Performance
-0.05%

Overall Performance
+518.85% (Including Options Trading +382.83%)
Monksdream Monksdream 8 minutos hace
Comparison chart
https://investorshub.advfn.com/uimage/uploads/2025/1/2/yqsdnIMG_4369.gif
RIGATONI RIGATONI 8 minutos hace
Previous shell wake up...

Small DTC

Held at DTC
1,890,000
01/02/2025

RELT .119

Took a few
RELT
Carjockey2 Carjockey2 8 minutos hace
Watching Notre Dame beat Georgia!!!

Can't you just say it or post it
QNCCF
RMS555 RMS555 9 minutos hace
DILUTION IS A CONCERN!!!!! 3.9 Billion Shares Diluted AFTER the WANNABE CEO stated there will be no more dilution in 2024. lolololol

PSRU is now in 2025 where it has been stated multiple times (by you) that there will be DILUTION!!!!


PSRU IS A SCAM , YOU KNOW
PSRU
TheHound TheHound 9 minutos hace
Nice consolidation with strong support. Five minutes until the candle prints. Let’s see if she runs following like she did yesterday.
XRPUSD
LTListener LTListener 9 minutos hace
I think it is board reads…

But why so much interest in this EM stock?

Continually..
RSPI
Stock_Barber Stock_Barber 9 minutos hace
Keep wondering...

All critical posters must be naked shorts... or so the crazy conspiracy theorists claim!

🤣
KEGS
ChannelTrader ChannelTrader 9 minutos hace
As Jews Warn of World War III in Israel, Christians Turn to ‘Our Lady of Palestine’

Video - https://remnant-tv.com/video/as-jews-warn-of-world-war-iii-in-israel-christians-turn-to-our-lady-of-palestine-
Guido2 Guido2 10 minutos hace
How? Their successors have the same authority to undo everything!
FNMA
StockInfo11 StockInfo11 10 minutos hace
This month, gold producer Heliostar Metals (HSTR.v HSTXF) plans to shift from residual leaching to mining operations at its La Colorada Mine in Mexico. Since August, HSTR has completed 57 drill holes, resource modeling, and metallurgical testing at the project, with results expected soon. More⬇️
HSTXF
RMS555 RMS555 11 minutos hace
Because there are too many naive people and they might bite on the resident pumpers of PSRU......

PSRU IS A SCAM, the top traders know this...... Xavier Mitchell is a WANNABE!!!!

.
PSRU
Hawkeiz Hawkeiz 12 minutos hace
I had a feeling we would start seeing a lot of news soon 
SINC

Su Consulta Reciente

Delayed Upgrade Clock